Thomas Phd Adams's Net Worth
$1.7 Million
Who is Thomas Phd Adams?
Thomas Phd Adams has an estimated net worth of $1.7 Million. This is based on reported shares across multiple companies, which include IRIS INTERNATIONAL INC, Synergy Pharmaceuticals, Inc., Hepion Pharmaceuticals, Inc., Cardiff Oncology, Inc., and LA JOLLA PHARMACEUTICAL CO.
SEC CIK
Thomas Phd Adams's CIK is 0001234366
Past Insider Trading and Trends
2012 was Thomas Phd Adams's most active year for acquiring shares with 12 total transactions. Thomas Phd Adams's most active month to acquire stocks was the month of May. 2011 was Thomas Phd Adams's most active year for disposing of shares, totalling 36 transactions. Thomas Phd Adams's most active month to dispose stocks was the month of May. 2006 saw Thomas Phd Adams paying a total of $4,200,022.50 for 320,375 shares, this is the most they've acquired in one year. In 2012 Thomas Phd Adams cashed out on 445,885 shares for a total of $6,907,648.42, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
IRIS INTERNATIONAL INC No price found
CTO & Corporate V.P.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -238.75K |
$16.02 | -$5,226,249.32 |
0
|
Oct 31
| |||
Form 4
| +4.31% | 293 |
—
|
—
| 7.09K |
Sep 30
| |||
Form 4
| +0.05% | 112 |
$11.30 | -$2,034.00 | 238.46K |
Jun 30
| |||
Form 4
| +0.01% | 24 |
$13.51 | -$3,620.68 | 238.35K |
Mar 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 27
| |||
Form 4
| +0.01% | 26 |
$9.35 | -$2,496.45 | 238.33K |
Dec 31
| |||
Form 4
| +0.01% | 24 |
$9.09 | -$2,436.12 | 238.3K |
Sep 30
| |||
Form 4
| +0.01% | 26 |
$10.00 | -$2,670.00 | 238.28K |
Jun 30
| |||
Form 4
| -7.92% | -20.00K |
$9.21 | -$184,255.70 | 232.38K |
Jun 16
| |||
Form 4
| -0.07% | -183.00 |
$9.08 | -$1,661.64 | 258.25K |
Mar 31
| |||
Form 4
| +0.26% | 677 |
$9.29 | -$4,570.68 | 258.43K |
Mar 23
| |||
Form 4
| -0.06% | -160.00 |
$10.20 | -$1,632.00 | 257.76K |
Dec 31
| |||
Form 4
| -0.06% | -159.00 |
$9.72 | -$1,545.48 | 257.92K |
Sep 30
| |||
Form 4
| -0.47% | -1.23K |
$10.73 | -$13,159.63 | 258.07K |
Mar 4 - Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 23
| |||
Form 4
| +1.22% | 3.13K |
—
|
—
| 259.3K |
Feb 20
| |||
Form 4
| -1.46% | -3.80K |
—
|
—
| 256.17K |
Mar 4
| |||
Form 4
| -6.31% | -17.00K |
$19.39 | -$329,701.70 | 252.38K |
Sep 18
| |||
Form 4
| -1.10% | -3.00K |
—
|
—
| 269.38K |
Jul 10
| |||
Form 4
|
∞
| 272.38K |
$15.42 | $4,200,022.50 | 272.38K |
Apr 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Synergy Pharmaceuticals, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 72.24K |
$0.50 | $50,011.50 | 72.24K |
Jul 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 28
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jun 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Hepion Pharmaceuticals, Inc. (HEPA) Snapshot price: $1.55
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Cardiff Oncology, Inc. (CRDF) Snapshot price: $1.72
Executive Chairman
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
| +286.07% | 13.99K |
$1.43 | $19,999.98 | 18.88K |
May 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 23
| |||
Form 4
| +4.97% | 16.67K |
—
|
—
| 351.96K |
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 4
| |||
Form 4
| +2.70% | 8.81K |
—
|
—
| 335.29K |
Sep 2
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 25
| |||
Form 4
| -5.55% | -19.20K |
$8.19 | -$157,188.00 | 326.49K |
Aug 30 - Sep 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
LA JOLLA PHARMACEUTICAL CO No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 18
| |||
| No matching records found | |||||||||